Bread and Butter Stack – RAD-140 + Nolvadex (Tamoxifen)

Research Compound Bundle | SARM + SERM

The Bread and Butter Stack by Vi Corpus combines two distinct compounds used in androgen and oestrogen receptor research: RAD-140 (Testolone), a selective androgen receptor modulator (SARM), and Tamoxifen (Nolvadex), a selective oestrogen receptor modulator (SERM).

These compounds have different pharmacological mechanisms and are studied in relation to receptor signalling, endocrine pathways and hormone-responsive biological processes.

This four-bottle bundle brings both compounds together in a single research package, with each supplied separately in a 30 mL liquid formulation.

What's Included

Compound	Concentration	Bottle Size	Quantity
RAD-140 (Testolone)	15 mg/mL	30 mL	3 bottles
Nolvadex (Tamoxifen)	20 mg/mL	30 mL	1 bottle

Total package: 4 × 30 mL bottles (120 mL).

Compound Information

RAD-140 (Testolone)

RAD-140, also known as Testolone or Vosilasarm, is an investigational nonsteroidal selective androgen receptor modulator (SARM).

RAD-140 has been investigated for its interaction with androgen receptors and its potential tissue-selective pharmacological activity.

Unlike testosterone and conventional anabolic androgenic steroids, RAD-140 is structurally nonsteroidal. Research has explored its receptor-binding characteristics, pharmacokinetics and androgen receptor-mediated cellular responses.

Key Research Areas:

• Selective androgen receptor binding and activation
• Androgen receptor signalling pathways
• Tissue-selective pharmacological activity
• Nonsteroidal androgen receptor modulators
• Pharmacokinetic and metabolic characteristics

Nolvadex (Tamoxifen)

Tamoxifen, commonly known by the brand name Nolvadex, belongs to the selective oestrogen receptor modulator (SERM) class.

Tamoxifen interacts with oestrogen receptors and can exhibit antagonistic or agonistic activity depending on the tissue involved. Its pharmacological characteristics have been extensively investigated in endocrine and hormone-responsive research.

Unlike compounds that directly inhibit oestrogen synthesis, tamoxifen primarily modifies oestrogen receptor activity.

Key Research Areas:

• Selective oestrogen receptor modulation
• Oestrogen receptor binding and signalling
• Tissue-dependent receptor responses
• Endocrine feedback mechanisms
• Tamoxifen metabolism and active metabolites

Product Specifications

Specification	Details
Product Name	Bread and Butter Stack
Brand	Vi Corpus
Compound 1	RAD-140 (Testolone / Vosilasarm)
Compound 2	Nolvadex (Tamoxifen)
Compound Classification	SARM + SERM
RAD-140 CAS Number	1182367-47-0
Tamoxifen CAS Number	10540-29-1
Tamoxifen Citrate CAS Number	54965-24-1
RAD-140 Concentration	15 mg/mL
Tamoxifen Concentration	20 mg/mL
Form	Liquid formulation
Bottle Size	30 mL each
Total Bottles	4
Total Volume	120 mL
Intended Purpose	Laboratory research only

Research and Scientific Background

RAD-140 and Tamoxifen are pharmacologically distinct compounds that interact with different nuclear hormone receptors.

RAD-140 has been investigated for its selective activity at androgen receptors, while Tamoxifen has an established research history involving tissue-specific oestrogen receptor modulation.

Their respective mechanisms provide research context for understanding androgen and oestrogen receptor pathways. However, the inclusion of both compounds in this bundle does not establish the safety or effectiveness of their combined administration.

Important Research Disclaimer

RAD-140 is an investigational compound and is not approved for human therapeutic use in Australia.

Tamoxifen is a prescription medicine in Australia. Its inclusion in a research-labelled bundle does not remove applicable requirements governing its supply.

This product description is provided for scientific and technical information only. It is not intended to recommend personal administration, bodybuilding cycles, post-cycle therapy or the treatment or prevention of any medical condition.

No claims are made regarding the safety, efficacy or therapeutic benefits of combining these compounds.